Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of erk1 and erk2 cascade"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MAPK1 | mitogen-activated protein kinase 1 | 1.000 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 1.000 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.999 | Human Rat | |
| C1QA | complement component 1, q subcomponent, A chain | 0.997 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.988 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.947 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.921 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.920 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.912 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.824 | Human | |
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.782 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.761 | ||
| GHR | growth hormone receptor | 0.743 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.610 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.546 | ||
| KLF6 | Kruppel-like factor 6 | 0.479 | ||
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.455 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.303 | ||
| RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.257 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.242 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.236 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.221 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.220 | ||
| KLHL3 | kelch-like 3 (Drosophila) | 0.218 | ||
| BCR | breakpoint cluster region | 0.213 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.198 | Human | |
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.171 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.168 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.150 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.135 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.126 | Mouse | |
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.126 | ||
| ARHGAP9 | Rho GTPase activating protein 9 | 0.118 | ||
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.099 | Human Fly | |
| GRB10 | growth factor receptor-bound protein 10 | 0.098 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.095 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.083 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.081 | ||
| RANBP3 | RAN binding protein 3 | 0.077 | ||
| IER2 | immediate early response 2 | 0.076 | ||
| ATF2 | activating transcription factor 2 | 0.073 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.060 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.058 | ||
| PXN | paxillin | 0.058 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.057 | ||
| MBP | myelin basic protein | 0.056 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.050 | ||
| INSR | insulin receptor | 0.049 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.045 | ||
| ATF3 | activating transcription factor 3 | 0.044 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.043 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.040 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.039 | ||
| JUN | jun proto-oncogene | 0.039 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.039 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.039 | ||
| MTPN | myotrophin | 0.039 | ||
| OXSR1 | oxidative-stress responsive 1 | 0.038 | ||
| LY96 | lymphocyte antigen 96 | 0.038 | ||
| IRS2 | insulin receptor substrate 2 | 0.037 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.036 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.036 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.036 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.035 | Human | |
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.035 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.035 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.034 | ||
| IER3 | immediate early response 3 | 0.034 | ||
| C19orf46 | chromosome 19 open reading frame 46 | 0.032 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.032 | ||
| MKNK1 | MAP kinase interacting serine/threonine kinase 1 | 0.031 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.030 | ||
| JUND | jun D proto-oncogene | 0.029 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.028 | ||
| SEC24D | SEC24 family, member D (S. cerevisiae) | 0.027 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.027 | ||
| MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 0.025 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.024 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.023 | ||
| RPS6KA4 | ribosomal protein S6 kinase, 90kDa, polypeptide 4 | 0.022 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.022 | ||
| IRS1 | insulin receptor substrate 1 | 0.022 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.021 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.020 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.020 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.020 | ||
| FZD5 | frizzled homolog 5 (Drosophila) | 0.019 | ||
| EGR1 | early growth response 1 | 0.018 | ||
| MYO6 | myosin VI | 0.018 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.017 | Human | |
| MARCO | macrophage receptor with collagenous structure | 0.017 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.017 | ||
| ZNF746 | zinc finger protein 746 | 0.017 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.016 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.016 | ||
| LDB2 | LIM domain binding 2 | 0.016 | ||
| SLC26A3 | solute carrier family 26, member 3 | 0.016 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.015 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.015 | ||
| CSDA | cold shock domain protein A | 0.015 | ||
| WDR1 | WD repeat domain 1 | 0.015 | ||
| ZNF71 | zinc finger protein 71 | 0.015 | ||
| FHL2 | four and a half LIM domains 2 | 0.015 | ||
| C10orf116 | chromosome 10 open reading frame 116 | 0.015 | ||
| DUSP4 | dual specificity phosphatase 4 | 0.015 | Human | |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.015 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.015 | ||
| IER5 | immediate early response 5 | 0.015 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.015 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.015 | ||
| EGR2 | early growth response 2 | 0.014 | ||
| FAM48A | family with sequence similarity 48, member A | 0.014 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.014 | ||
| CMTM6 | CKLF-like MARVEL transmembrane domain containing 6 | 0.014 | ||
| DUSP16 | dual specificity phosphatase 16 | 0.014 | Human | |
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.014 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.014 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.013 | ||
| CTBP1 | C-terminal binding protein 1 | 0.013 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.013 | ||
| ITGA1 | integrin, alpha 1 | 0.013 | ||
| APOA1 | apolipoprotein A-I | 0.013 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.013 | ||
| MSH5 | mutS homolog 5 (E. coli) | 0.013 | ||
| RALYL | RALY RNA binding protein-like | 0.013 | ||
| ARRB1 | arrestin, beta 1 | 0.012 | ||
| DGCR14 | DiGeorge syndrome critical region gene 14 | 0.012 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.012 | ||
| JUNB | jun B proto-oncogene | 0.012 | ||
| CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0.012 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.011 | ||
| EGFR | epidermal growth factor receptor | 0.011 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.011 | Mouse | |
| MAPK11 | mitogen-activated protein kinase 11 | 0.011 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.011 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.011 | ||
| BTN2A1 | butyrophilin, subfamily 2, member A1 | 0.011 | Mouse | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.011 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.011 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.011 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.011 | ||
| KLHL2 | kelch-like 2, Mayven (Drosophila) | 0.011 | ||
| C1S | complement component 1, s subcomponent | 0.011 | ||
| POLR2L | polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa | 0.010 | ||
| LMO4 | LIM domain only 4 | 0.010 | Human | |
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.010 |